LOINC Home

{component}   LP432695-7

Clinical   LP7787-7

Clinical terms not yet categorized   LP248771-0

Stage/prognostic factors section Set NAACCR v.12   60508-9

LOINC Code


LOINC code60508-9
nameStage/prognostic factors section Set NAACCR v.12
statusACTIVE

Fully-Specified Name

componentStage &or prognostic factors section
property-
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system^Patient
scaleSet  =  Set:  Used for clinical attachments
methodNAACCR v.12

Additional Names

short nameStage/prognost fact section NAACCR v.12

Basic Attributes

classTUMRRGT
type2  Clinical

Panel Components

42037-2Scope of regional lymph node surgery at this facility 98-02 Cancer
39806-5Summary stage at Dx 2000 revised Cancer
42038-0Surgery of other regional site(s), distant site(s), or distant lymph node(s) at this facility 98-02 Cancer
39806-5Summary stage at Dx 2000 revised Cancer
21887-5SEER summary stage 1977 Cancer
21888-3Summary stage abbreviated at Dx Cancer
21889-1Size Tumor
21890-9Extension Cancer
21891-7Extent of disease Prostate cancer
21892-5Lymph node involvement Cancer
21893-3Regional lymph nodes positive [#] Specimen
21894-1Regional lymph nodes examined [#] Specimen
21895-8Extent of disease.NAACCR.old 13 digit
21896-6Extent of disease.NAACCR.old 2 digit
21897-4Extent of disease.NAACCR.old 4 digit
21898-2Version used Extent of disease coding system
21917-0Version used [Identifier] TNM classification
21899-0Primary tumor.pathology Cancer
21900-6Regional lymph nodes.pathology [Class] Cancer
21901-4Distant metastases.pathology [Class] Cancer
21902-2Stage group.pathology Cancer
21903-0Descriptor.pathology Cancer Narrative
21904-8Stager.pathology Cancer
21905-5Primary tumor.clinical [Class] Cancer
21906-3Regional lymph nodes.clinical [Class] Cancer
21907-1Distant metastases.clinical [Class] Cancer
21908-9Stage group.clinical Cancer
21909-7Descriptor.clinical Cancer Narrative
21910-5Stager.clinical Cancer
21921-2Pediatric stage Cancer
21922-0Coding system used Cancer pediatric staging
21923-8Pediatric cancer stager
21924-6Tumor marker Cancer
59544-7Lymph-vascular invasion Cancer specimen
42079-4Tumor size.collaborative staging
42080-2Extension collaborative staging Cancer
42081-0Collaborative staging tumor size extension evaluation Cancer
42082-8Collaborative staging lymph nodes Cancer
42083-6Collaborative staging regional nodes evaluation Cancer
42084-4Collaborative staging metastasis at diagnosis Cancer
42085-1Collaborative staging metastasis evaluation Cancer
59475-4Collaborative staging metastasis at diagnosis - bone involvement Cancer
59476-2Collaborative staging metastasis at diagnosis - brain involvement Cancer
59477-0Collaborative staging metastasis at diagnosis - liver involvement Cancer
59478-8Collaborative staging metastasis at diagnosis - lung involvement Cancer
42086-9Collaborative staging site-Specific factor 1 Cancer
42087-7Collaborative staging site-Specific factor 2 Cancer
42088-5Collaborative staging site-Specific factor 3 Cancer
42089-3Collaborative staging site-Specific factor 4 Cancer
42090-1Collaborative staging site-Specific factor 5 Cancer
42091-9Collaborative staging site-Specific factor 6 Cancer
59489-5Collaborative staging site-specific factor 7 Cancer
59490-3Collaborative staging site-specific factor 8 Cancer
59491-1Collaborative staging site-specific factor 9 Cancer
59492-9Collaborative staging site-specific factor 10 Cancer
59493-7Collaborative staging site-specific factor 11 Cancer
59494-5Collaborative staging site-specific factor 12 Cancer
59495-2Collaborative staging site-specific factor 13 Cancer
59496-0Collaborative staging site-specific factor 14 Cancer
59497-8Collaborative staging site-specific factor 15 Cancer
59498-6Collaborative staging site-specific factor 16 Cancer
59499-4Collaborative staging site-specific factor 17 Cancer
59500-9Collaborative staging site-specific factor 18 Cancer
59501-7Collaborative staging site-specific factor 19 Cancer
59503-3Collaborative staging site-specific factor 21 Cancer
59504-1Collaborative staging site-specific factor 22 Cancer
59505-8Collaborative staging site-specific factor 23 Cancer
59506-6Collaborative staging site-specific factor 24 Cancer
59507-4Collaborative staging site-specific factor 25 Cancer
59488-7Collaborative staging pre treatment tumor size Cancer
59559-5Collaborative staging pre treatment extension Cancer
59487-9Collaborative staging pre treatment tumor size and extension evaluation Cancer
59483-8Collaborative staging pre treatment lymph nodes Cancer
59486-1Collaborative staging pre treatment regional nodes evaluation Cancer
59484-6Collaborative staging pre treatment metastasis at diagnosis Cancer
59482-0Collaborative staging post treatment tumor size Cancer
59479-6Collaborative staging post treatment extension Cancer
59480-4Collaborative staging post treatment lymph nodes Cancer
59481-2Collaborative staging post treatment metastasis at diagnosis Cancer
42094-3Derived American Joint Committee on Cancer T Derived
42095-0Derived American Joint Committee on Cancer T descriptor
42096-8Derived American Joint Committee on Cancer N
42097-6Derived American Joint Committee on Cancer N descriptor
42098-4Derived American Joint Committee on Cancer M
42099-2Derived American Joint Committee on Cancer M descriptor
42100-8Derived American Joint Committee on Cancer stage group
59527-2Derived American Joint Committee on Cancer-7 T
59528-0Derived American Joint Committee on Cancer-7 T descriptor
59524-9Derived American Joint Committee on Cancer-7 N
59525-6Derived American Joint Committee on Cancer-7 N descriptor
59522-3Derived American Joint Committee on Cancer-7 M
59523-1Derived American Joint Committee on Cancer-7 M descriptor
59526-4Derived American Joint Committee on Cancer-7 stage group
59539-7Derived pre treatment-7 T Cancer
59540-5Derived pre treatment-7 T descriptor Cancer
59536-3Derived pre treatment-7 N Cancer
59537-1Derived pre treatment-7 N descriptor Cancer
59534-8Derived pre treatment-7 M Cancer
59535-5Derived pre treatment-7 M descriptor Cancer
59538-9Derived pre treatment-7 stage group Cancer
59533-0Derived post treatment-7 T Cancer
59531-4Derived post treatment-7 N Cancer
59530-6Derived post treatment-7 M Cancer
59532-2Derived post treatment-7 stage group Cancer
42101-6Derived SEER summary stage 1977 Cancer
42102-4Derived SEER summary stage 2000 Cancer
59529-8Flag for Derived neoadjuvant therapy not populated Cancer
42103-2Derived American Joint Committee on Cancer conversion method
42104-0Derived SEER summary stage 1977 conversion method Cancer
42105-7Derived SEER summary stage 2000 conversion method Cancer
59508-2Collaborative staging version.current Cancer
42092-7Collaborative staging version.first Cancer
42093-5Collaborative staging version.latest Cancer
42126-3Comorbidities and complications 1
59858-1SEER site-specific fact 1 [Identifier] Cancer
59859-9SEER site-specific fact 2 [Identifier] Cancer
59860-7SEER site-specific fact 3 [Identifier] Cancer
59861-5SEER site-specific fact 4 [Identifier] Cancer
59862-3SEER site-specific fact 5 [Identifier] Cancer
59863-1SEER site-specific fact 6 [Identifier] Cancer
42116-4ICD revision comorbidities Cancer
42126-3Comorbidities and complications 1
42107-3Comorbidities and complications 2
42108-1Comorbidities and complications 3
42109-9Comorbidities and complications 4
42110-7Comorbidities and complications 5
42111-5Comorbidities and complications 6
42112-3Comorbidities and complications 7
42113-1Comorbidities and complications 8
42114-9Comorbidities and complications 9
42115-6Comorbidities and complications 10

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

59852-4North American Association of Central Cancer Registries, Inc (NAACCR, Inc) version 12 panel

History/Usage

first released
last updated2.61
last change typeMIN  - change to field other than name

Related Names

North American Association of Central Cancer Registries
Oncology
Point in time
 Random
Stage/prognost fact section
TUMOR REGISTRY(NAACCR)

Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2023, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.